These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9865314)

  • 1. Functional characterization of HP12: a novel immunosuppressant purified from Helleborus species.
    Linke S; Dufter C; Kerek F; Jung M; Watzlik A; Jung T; Opelz G; Terness P
    Transplant Proc; 1998 Dec; 30(8):4106-7. PubMed ID: 9865314
    [No Abstract]   [Full Text] [Related]  

  • 2. HP12: a highly purified Helleborus species extract strongly potentiates the T-cell suppressive effect of cyclosporine A.
    Terness P; Dufter C; Linke S; Kerek F; Jung T; Watzlik A; Opelz G
    Transplant Proc; 1999; 31(1-2):1174-5. PubMed ID: 10083524
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does immune activation continue during an attack-free period in familial Mediterranean fever?
    Musabak U; Sengul A; Oktenli C; Pay S; Yesilova Z; Kenar L; Sanisoglu SY; Inal A; Tuzun A; Erdil A; Bagci S
    Clin Exp Immunol; 2004 Dec; 138(3):526-33. PubMed ID: 15544632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation antigens expressed on T-cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Exp Rheumatol; 1990; 8(3):243-9. PubMed ID: 1974181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous lymphocyte-monocyte co-culture increases NMR-visible and cytoplasmic lipids in the absence of increased markers of lymphocyte activation.
    Delikatny EJ; van Holst Pellekaan CJ; King NJ
    Biochim Biophys Acta; 2001 Oct; 1533(3):243-54. PubMed ID: 11731334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506.
    Keenan R; Kaufman C; Zeevi A; Yousem S; Zerbe T; Armitage J; Kormos R; Duquesnoy R; Griffith B; Starzl T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1162-4. PubMed ID: 1671178
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms.
    Borron PJ; Mostaghel EA; Doyle C; Walsh ES; McHeyzer-Williams MG; Wright JR
    J Immunol; 2002 Nov; 169(10):5844-50. PubMed ID: 12421966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of cytokine production in human cord blood and peripheral blood from healthy donors before and after allogeneic activation: relevance in predicting graft-versus-host disease.
    Paiva A; Ferreira T; Freitas A; Couceiro A; Coimbra H; Regateiro FJ
    Transplant Proc; 2000 Dec; 32(8):2626-30. PubMed ID: 11134731
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes.
    Bischof F; Melms A
    Cell Immunol; 1998 Jul; 187(1):38-44. PubMed ID: 9682002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.
    Johansson A; Möller E
    Transplantation; 1990 Dec; 50(6):1001-7. PubMed ID: 1701570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rhG-CSF on the conformation of LFA-1 on CD4+ T cells in hemopoietic stem cell transplantation.
    Weihua C; Fei W; Meng L; Haiyan Z; Wanming D; Chunji G
    Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):267-73. PubMed ID: 19235605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens.
    Antas PR; Oliveira EB; Milagres AS; Franken KC; Ottenhoff TH; Klatser P; Sarno EN; Sampaio EP
    Mem Inst Oswaldo Cruz; 2002 Dec; 97(8):1097-9. PubMed ID: 12563472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fluorochromasia assay for sensitivity of lymphocytes to immunosuppressants.
    Tamaki T; Konoeda Y; Kozaki M; Ozawa S; Yamazaki I
    Transplant Proc; 1992 Aug; 24(4):1413-6. PubMed ID: 1496602
    [No Abstract]   [Full Text] [Related]  

  • 15. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extract of the fern Polypodium leucotomos inhibits human peripheral blood mononuclear cells proliferation in vitro.
    Rayward J; Villarrubia VG; Guillen C; Prieto A; Rodriguez-Zapata M; Sada G; Alvarez-Mon M
    Int J Immunopharmacol; 1997 Jan; 19(1):9-14. PubMed ID: 9226474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy.
    Saito S; Nishikawa K; Morii T; Narita N; Enomoto M; Ichijo M
    Immunology; 1992 Apr; 75(4):710-2. PubMed ID: 1592443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.